< Back to catalogue
Everolimus/Pharmazac
July 15, 2026Lurasidone/Pharmazac
July 15, 2026PHARMAZAC
Hedimal®
Sumatriptan | Antimigraine agent | CNS
| HEDIMAL NASPR.SOL 100MG/ML BT x 1 VIAL x 1.8ML |
| HEDIMAL NASPR.SOL 100MG/ML BT x 1 VIAL x 1.8ML |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | Provident Pharmaceuticals Ltd |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
